Poppy Grace arrived in the world radiating light. Even as an infant, she brought joy and warmth, smiling openly and forming connections with those around her. Her parents, Carly and Tresne, quickly recognized her remarkable empathy and social skills—traits that were extraordinary for a baby. Life appeared to hold great promise, but at just six weeks old, a bruise on her thigh hinted at a struggle that would test the entire family.
Initially thought to be a minor bruise, this mark was an early indication of something far more serious. As the weeks went by, Poppy’s health began to decline. She had trouble sleeping, cried frequently, and eventually started projectile vomiting. Alarmed, Carly and Tresne took her to the hospital, where a pediatrician noted her pale complexion and swollen abdomen. Blood tests indicated a dangerously elevated white blood cell count and critically low hemoglobin—signs that their little girl was already in a fight for her life.
Within hours, Poppy was admitted to the John Hunter Oncology Day Unit, but strict COVID-19 protocols complicated the situation. Only one parent could be with her at a time, leaving Tresne heartbroken outside while Carly rushed to Poppy’s side. Emergency staff struggled to find a vein, as her blood was thickened by leukemia, and she was quickly prepared for surgery to insert a temporary IV line. Carly and Tresne were informed that Poppy’s chances of surviving the procedure were uncertain.
Incredibly, Poppy survived the surgery and was moved to the Paediatric Intensive Care Unit (PICU). She was diagnosed with high-risk infantile acute lymphoblastic leukemia, a rare type that affects only five to six infants in Australia each year. The prognosis was bleak: doctors estimated her survival chances at just 20%, compounded by her age, extremely high white cell count, and the MLL gene mutation. The first two days were filled with fear and heartbreak for her parents, who cherished every moment with their long-awaited daughter.
From the outset, Poppy exhibited remarkable resilience. She underwent 547 days of intensive treatment, which included 405 overnight hospital stays and only two or three days at home at a time. Her treatment was arduous: 129 rounds of chemotherapy, 113 blood transfusions, 37 lumbar punctures, 20 X-rays, 15 ultrasounds, nine CT scans, six MRIs, two rounds of immunotherapy, daily steroids, and countless medications. Throughout it all, Poppy faced each obstacle with a smile, laughter, and even dance moves that amazed her doctors.
Four months into her treatment, Poppy began her first round of immunotherapy, but the leukemia relapsed. She returned to PICU, where she suffered from severe chemotoxicity, mucositis, and persistent vomiting. The battle continued, with her doctors and the ZERO Childhood Cancer team testing drugs on cells derived from Poppy’s leukemia to discover effective, targeted treatments. These efforts are vital for developing therapies that attack cancer cells while minimizing the suffering of these young patients.
Despite these advancements, Poppy experienced a second relapse after her first birthday. Her family looked into CAR-T cell therapy, a groundbreaking treatment that genetically modifies a child’s T cells to combat leukemia. Meanwhile, compassionate use of a trial drug, Venetoclax, provided temporary management of her leukemia without severe side effects. For eight months, Poppy’s condition fluctuated, her small body enduring every treatment with remarkable bravery.
In her final weeks, Poppy’s parents prioritized joy and comfort. She spent her days reading her favorite books, dancing to silly songs, and playing with Christmas toys. Her laughter, curiosity, and fierce spirit remained strong until the very end. Poppy passed away peacefully on February 16, 2023, at just 20 months old.
Though her life was short, Poppy’s influence endures. She inspired many with her resilience, joy, and determination to live fully despite overwhelming challenges. Carly and Tresne have honored her memory by promoting blood donations and fundraising for the Children’s Cancer Institute, supporting research into infant leukemia. Their efforts aim to develop targeted therapies that can destroy cancer cells while preserving healthy tissue—therapies that could provide other children with the fighting chance that Poppy deserved.
Poppy’s story exemplifies the strength of a child and the dedication of parents confronted with a life-threatening diagnosis. Her bravery encourages us to face childhood cancer not with despair, but with action: to fund research, support families, and relentlessly pursue better treatments. Her laughter, dance moves, and smiles will forever resonate in the hearts of all who knew her, reminding us that even in the briefest lives, immense light can shine.
Poppy Grace was more than just a patient; she was a warrior, a teacher, and an inspiration. In her tiny frame, she held courage vast enough to inspire a community, and in her memory, her family continues to fight, determined to ensure that the next child with leukemia has hope—and a chance to dance through life, just as Poppy did.
